Unveiling the pain of autoimmunity: EliA assay technology in women's health
Date: Wednesday, July 30, 2025 | Time: 11:30 - 11:55 AM | Booth: 2812
This micro-lecture will address the disproportionate impact of autoimmune diseases on women and the crucial role of EliATM autoimmune assays in providing timely and accurate diagnosis. Participants will explore the higher prevalence of autoimmune conditions like rheumatoid arthritis, lupus and antiphospholipid syndrome among women, as well as the disproportionate rates of delayed or misdiagnosis. The session will emphasize how EliATM autoimmune tests aid in diagnosis, offering hope and impacting patient outcomes. Through case studies and real-world examples, attendees will gain a deeper understanding of the unique challenges faced by women with autoimmune diseases and how EliA autoimmune assay technology is transforming their diagnostic journey and care.
Learning Objectives:
- Recognize the impact of gender disparity within autoimmune disease: Laboratory professionals will understand the broader consequence of gender disparity in healthcare, particularly women's health, and how the laboratory is perfectly situated to drive effective change.
- Enhance diagnostic accuracy with EliA autoimmune assay technology: Attendees will learn how EliA autoimmune tests can be used to achieve precise and early detection of autoimmune diseases in women, supporting improved diagnostic efficiency and reliability.
- Support women's health through effective laboratory guidance: Participants will explore lab-focused strategies which enhance the diagnostic confidence of providers and ultimately impact many gender specific care gaps felt by women facing an autoimmune diagnosis.